|
CDK13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.98980004590044E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51145999999214E-05 |
| Normal-vs-Stage2 |
2.362000E-02 |
| Normal-vs-Stage3 |
2.385400E-01 |
| Normal-vs-Stage4 |
1.595960E-01 |
| Stage1-vs-Stage2 |
3.547200E-01 |
| Stage1-vs-Stage3 |
5.038200E-02 |
| Stage1-vs-Stage4 |
2.923000E-01 |
| Stage2-vs-Stage3 |
9.452200E-02 |
| Stage2-vs-Stage4 |
1.956810E-01 |
| Stage3-vs-Stage4 |
6.678600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.16660000232849E-08 |
| Normal-vs-AfricanAmerican |
1.664340E-03 |
| Normal-vs-Asian |
3.876900E-03 |
| Caucasian-vs-AfricanAmerican |
9.076200E-01 |
| Caucasian-vs-Asian |
9.560800E-01 |
| AfricanAmerican-vs-Asian |
9.904800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.18129999513184E-08 |
| Normal-vs-Female |
6.38290000000152E-05 |
| Male-vs-Female |
7.919600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.366220E-02 |
| Normal-vs-Extreme_Weight |
8.247400E-04 |
| Normal-vs-Obese |
1.011350E-04 |
| Normal-vs-Extreme_Obese |
3.804200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.251800E-01 |
| Normal_Weight-vs-Obese |
4.727200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.890000E-01 |
| Extreme_Weight-vs-Obese |
7.175600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.738200E-01 |
| Obese-vs-Extreme_Obese |
3.886400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.598870E-03 |
| Normal-vs-Age(41-60Yrs) |
4.28519997264232E-09 |
| Normal-vs-Age(61-80Yrs) |
1.646240E-04 |
| Normal-vs-Age(81-100Yrs) |
7.934200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.481000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.501000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.017430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.468000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.747900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.756600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.18769447002387E-12 |
| Normal-VS-Type2 PRCC |
7.817000E-01 |
| Normal-VS-KIRP CIMP |
3.246600E-01 |
| Normal-VS-Unclassified PRCC |
1.177950E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.15669999823621E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.937710E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.496200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.089800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.435700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.024230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.383570E-01 |
| Normal-vs-N1 |
2.082500E-02 |
| Normal-vs-N2 |
9.246200E-01 |
| N0-vs-N1 |
2.254400E-01 |
| N0-vs-N2 |
6.665800E-01 |
| N1-vs-N2 |
3.308400E-01 |
|
|
